Bristol Myers Squibb (BMS) announced it is deploying a second NVIDIA DGX SuperPOD, this one built on NVIDIA Vera Rubin. According to the source, the pharmaceutical company already operates one of the largest AI clusters in life sciences and is expanding that infrastructure. An individual named Erin Davis refers to the effort as the “SuperDuperPOD.”
Why it matters
The move represents a scaling of AI computing capacity within a major life sciences organization, adding a second SuperPOD to an existing cluster.
Who should care
Enterprises in the life sciences and pharmaceutical sectors, as well as teams evaluating large-scale AI infrastructure, may find this deployment relevant.